TUXEDO: A Phase I/II Trial of Cetuximab with Chemoradiotherapy in Muscle-Invasive Bladder Cancer.
BJU international（2022）
关键词
muscle-invasive bladder cancer,cetuximab,clinical trial,chemoradiotherapy,feasibility,#BladderCancer,#blcsm,#uroonc
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要